anurajms/meta_analysis huggingface dataset:
Interventions:
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease
1. COPD Action Plan
Interventions:
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
1. Pulmonary Rehabilitation
Interventions:
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1. Oxygen Therapy
Interventions:
Upper limb exercise training for COPD
1. Lower Limb Exercises 2. Upper Limb Exercises
Interventions:
Exhaled nitric oxide levels to guide treatment for children with asthma
1. Respired Nitric Oxide Monitoring 2. Guidance Intent
Interventions:
Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD
1. Nebulizer Therapy 2. Inhaled Bronchodilator Therapy
Interventions:
Smoking cessation for people with chronic obstructive pulmonary disease
1. Smoking Cessation Therapy 2. Smoking Cessation Drug Therapy
Interventions:
Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants
1. Endothelin Receptor Antagonist 2. Nitric Oxide 3. Inhaled
Interventions:
Home telemonitoring and remote feedback between clinic visits for asthma
1. Telehealth Monitoring 2. Ongoing Review 3. Healthcare Professional 4. Home
Interventions:
Guanylate cyclase stimulators for pulmonary hypertension
1. Riociguat
Interventions:
Codeine versus placebo for chronic cough in children
1. Oral 2. Codeine
Interventions:
Ambulatory and short‐burst oxygen for interstitial lung disease
1. Ambulatory Oxygen Therapy
Interventions:
Combination inhaled steroid and long‐acting beta2‐agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
1. Tiotropium 2. Corticosteroids - Inhaled 3. Long-Acting Beta-Agonists
Interventions:
Different oral corticosteroid regimens for acute asthma
1. Glucocorticoids - Systemic 2. Oral
Interventions:
Intravenous magnesium sulfate for treating children with acute asthma in the emergency department
1. Intravenous 2. Magnesium Sulfate
Interventions:
Remote versus face‐to‐face check‐ups for asthma
1. Telehealth Monitoring 2. Ongoing Review 3. Home
Interventions:
Breathing exercises for children with asthma
1. Breathing Exercises
Interventions:
High‐frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome
1. High Frequency Oscillatory Ventilation
Interventions:
Combined pharmacotherapy and behavioural interventions for smoking cessation
1. Smoking Cessation Therapy 2. Pharmacotherapy 3. Behavioral Therapy
Interventions:
Protocolized versus non‐protocolized weaning for reducing the duration of invasive mechanical ventilation in newborn infants
1. Weaning From Mechanically Assisted Ventilation
Interventions:
Smoking cessation advice for people with serious mental illness
1. Smoking Cessation Therapy
Interventions:
Inhaled non‐steroid anti‐inflammatories for children and adults with bronchiectasis
1. Non-steroidal Anti-inflammatory Drug 2. Inhaled
Interventions:
Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta2‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
1. Inhaled Anticholinergics 2. Corticosteroids - Inhaled 3. Long-Acting Beta-Agonists 4. Inhaled
Interventions:
Comparison of animal‐derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants
1. Animal-derived Surfactant 2. Prophylaxis
Interventions:
Addition of long‐acting beta2‐agonists to inhaled corticosteroids for chronic asthma in children
1. Corticosteroids - Inhaled 2. Salmeterol 3. Formoterol
Interventions:
Airway clearance techniques for bronchiectasis
1. Chest Physiotherapy
Interventions:
Interventions for enhancing adherence to treatment in adults with bronchiectasis
1. Reinforcement Of Adherence To Treatment Regimen
Interventions:
Exercise training to improve exercise capacity and quality of life in people with non‐malignant dust‐related respiratory diseases
1. Exercise therapy
Interventions:
Interventions for smokeless tobacco use cessation
1. Drug Therapy 2. Behavioral Therapy
Interventions:
Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease
1. Tiotropium 2. Long-Acting Beta-Agonists
Interventions:
Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children
1. Oral 2. Leukotriene Receptor Antagonists
Interventions:
Tonsillectomy or adenotonsillectomy versus non‐surgical management for obstructive sleep‐disordered breathing in children
1. Tonsillectomy 2. Tonsillectomy And Adenoidectomy
Interventions:
Calcium channel blockers for pulmonary arterial hypertension
1. Calcium Channel Blockers
Interventions:
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
1. Tiotropium
Interventions:
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
1. Tiotropium 2. Aclidinium Bromide 3. Corticosteroids - Inhaled 4. Glycopyrronium Bromide
Interventions:
Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome
1. Animal-derived Surfactant
Interventions:
Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults
1. Antibacterials For Systemic Use 2. Prophylaxis
Interventions:
Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
1. Corticosteroids - Inhaled 2. Inhaled
Interventions:
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
1. Tiotropium 2. Aclidinium Bromide 3. Corticosteroids - Inhaled 4. Glycopyrronium Bromide
Interventions:
Effects of opioid, hypnotic and sedating medications on sleep‐disordered breathing in adults with obstructive sleep apnoea
1. Opioids 2. Hypnotics And Sedatives
Interventions:
Stopping long‐acting beta2‐agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids
1. Corticosteroids - Inhaled
Interventions:
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma
1. Aclidinium Bromide 2. Tiotropium 3. Corticosteroids - Inhaled 4. Glycopyrronium Bromide
Interventions:
Stopping long‐acting beta2‐agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids
1. Corticosteroids - Inhaled
Interventions:
Pulmonary rehabilitation for chronic obstructive pulmonary disease
1. Pulmonary Rehabilitation
Interventions:
Pressure‐controlled versus volume‐controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS)
1. Pressure Controlled Ventilation
Interventions:
Early versus late tracheostomy for critically ill patients
1. Early Treatment 2. Tracheostomy
Interventions:
Indacaterol, a once‐daily beta2‐agonist, versus twice‐daily beta2‐agonists or placebo for chronic obstructive pulmonary disease
1. Indacaterol
Interventions:
Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients
1. Dexmedetomidine 2. Clonidine
Interventions:
Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants
1. Pentoxifylline 2. Nebulizer Therapy
Interventions:
Aclidinium bromide for stable chronic obstructive pulmonary disease
1. Aclidinium Bromide
Interventions:
Automated weaning and SBT systems versus non‐automated weaning strategies for weaning time in invasively ventilated critically ill adults
1. Weaning From Mechanically Assisted Ventilation 2. Trial For Spontaneous Breathing 3. Automatic Monitoring
Interventions:
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
1. Glucocorticoids - Systemic 2. Parenteral 3. Oral
Interventions:
Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery
1. Continuous Positive Airway Pressure Ventilation
Interventions:
Inhaled anticholinergics and short‐acting beta2‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital
1. Anticholinergics 2. Selective Beta-2-adrenoreceptor Agonists - Systemic 3. Inhaled
Interventions:
Tiotropium versus placebo for chronic obstructive pulmonary disease
1. Tiotropium 2. Inhaled
Interventions:
Water‐based exercise for adults with asthma
1. Swimming Pool 2. Physical therapy exercises
Interventions:
Inhaled corticosteroids in children with persistent asthma: effects on growth
1. Corticosteroids - Inhaled 2. Drug Therapy
Interventions:
Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth
1. Corticosteroids - Inhaled 2. Low Dose 3. Inhaled
Interventions:
Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest
1. Ambulatory Oxygen Therapy
Interventions:
Combination inhaled corticosteroids and long‐acting beta2‐agonists for children and adults with bronchiectasis
1. Corticosteroids - Inhaled 2. Long-Acting Beta-Agonists
Interventions:
Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department
1. Intravenous 2. Magnesium Sulfate
Interventions:
Written emotional disclosure for asthma
1. Writing Therapy
Interventions:
Non‐invasive ventilation during exercise training for people with chronic obstructive pulmonary disease
1. Exercise therapy 2. Non-invasive mechanical ventilation
Interventions:
Mucolytics for bronchiectasis
1. Mucolytic 2. Oral 3. Inhaled
Interventions:
Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis
1. Tiotropium 2. Aclidinium Bromide 3. Budesonide 4. Mometasone furoate 5. Salmeterol 6. Formoterol 7. Glycopyrronium Bromide 8. Indacaterol 9. Fluticasone 10. Inhaled
Interventions:
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
1. Vilanterol 2. Budesonide 3. Salmeterol 4. Formoterol 5. Fluticasone
Interventions:
Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma
1. Corticosteroids - Inhaled 2. Salmeterol 3. Formoterol
Interventions:
Water‐based exercise training for chronic obstructive pulmonary disease
1. Swimming Pool 2. Exercise therapy
Interventions:
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children
1. Budesonide 2. Formoterol 3. Inhaled
Interventions:
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure
1. Weaning From Mechanically Assisted Ventilation 2. Non-invasive positive pressure ventilation 3. Extubation Of Trachea
Interventions:
Antibody induction therapy for lung transplant recipients
1. Muromonab-cd3 2. Antithymocyte Immunoglobulin 3. Immunosuppressive Therapy For Transplant 4. Antilymphocyte Immunoglobulin 5. Alemtuzumab 6. Interleukin 2 Receptor Alpha
Interventions:
Smartphone and tablet self management apps for asthma
1. Smartphone app 2. Asthma Self Management
Interventions:
Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease
1. Thyrotropin Releasing Hormone (trh) Stimulation Test 2. Corticosteroids - Systemic use
Interventions:
Prostaglandins before caesarean section for preventing neonatal respiratory distress
1. Prostaglandins
Interventions:
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
1. Fluticasone Propionate 2. Budesonide 3. Mometasone furoate 4. Salmeterol 5. Formoterol
Interventions:
Long‐acting beta2‐agonists for chronic obstructive pulmonary disease
1. Salmeterol 2. Formoterol
Interventions:
Beclometasone for chronic obstructive pulmonary disease
1. Beclometasone
Interventions:
Addition of anti‐leukotriene agents to inhaled corticosteroids in children with persistent asthma
1. Corticosteroids - Inhaled 2. Oral 3. Leukotriene Receptor Antagonists 4. Inhaled
Interventions:
Beta2‐agonists for exercise‐induced asthma
1. Selective Beta-2-adrenoreceptor Agonists- Inhaled
Interventions:
Physical training for asthma
1. Aerobic Exercise 2. Education 3. Drug Therapy
Interventions:
Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma
1. Nebulizer Therapy 2. Selective Beta-2-adrenoreceptor Agonists - Systemic
Interventions:
Inspiratory muscle training for asthma
1. Inspiratory Muscle Training
Interventions:
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease
1. Mometasone furoate 2. Fluticasone Propionate 3. Budesonide 4. Salmeterol 5. Formoterol
Interventions:
Combined inhaled anticholinergics and short‐acting beta2‐agonists for initial treatment of acute asthma in children
1. Inhaled Anticholinergics 2. Selective Beta-2-adrenoreceptor Agonists - Systemic
Interventions:
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome
1. Fluorocarbon Ventilation 2. Low Dose 3. Liquid Ventilation
Interventions:
Combination inhaled steroid and long‐acting beta2‐agonist versus tiotropium for chronic obstructive pulmonary disease
1. Corticosteroids - Inhaled 2. Long-Acting Beta-Agonists
Interventions:
Drug therapy for obstructive sleep apnoea in adults
1. Drug Therapy
Interventions:
Physician advice for smoking cessation
1. Referral To Smoking Cessation Advisor 2. Physician
Interventions:
Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children
1. Preventive 2. Budesonide 3. Formoterol 4. Therapeutic Intent 5. Single-inhaler 6. Inhaled
Interventions:
Swimming training for asthma in children and adolescents aged 18 years and under
1. Swimming Pool 2. Swimming
Interventions:
Inhaled corticosteroids for subacute cough in children
1. Corticosteroids - Inhaled
Interventions:
Lung protective ventilation strategy for the acute respiratory distress syndrome
1. Assisted Ventilation Therapy, Pressure Or Volume Preset, Initiation And Management
Interventions:
Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome
1. Fluorocarbon Ventilation 2. Low Dose 3. Liquid Ventilation 4. Mechanical ventilation
Interventions:
Ciclesonide versus other inhaled corticosteroids for chronic asthma in children
1. Ciclesonide
Interventions:
Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults
1. Corticosteroids - Inhaled 2. Intermittent Administration
Interventions:
Psychosocial interventions for reducing antipsychotic medication in care home residents
1. Health Promotion Education 2. Communication Interventions 3. Formal Psychological Therapy
Interventions:
Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings
1. Restraint Removal
Interventions:
Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia
1. Cognitive Behavioral Therapy
Interventions:
Cognitive rehabilitation for people with mild to moderate dementia
1. Cognitive rehabilitation therapy
Interventions:
Personally tailored activities for improving psychosocial outcomes for people with dementia in long‐term care
1. Development Of Individualized Plan Of Care 2. Tailored Intervention
Interventions:
Cognitive stimulation to improve cognitive functioning in people with dementia
1. Cognitive Stimulation
Interventions:
Non‐pharmacological interventions for sleep disturbances in people with dementia
1. Non-Pharmacological Interventions
Interventions:
Pharmacological interventions for the treatment of disordered and problem gambling
1. Noradrenergic and specific serotonergic antidepressants 2. Monoamine oxidase inhibitors 3. Mood stabilisers 4. Anticonvulsants 5. Melatonin Receptor Agonists 6. Noradrenaline Reuptake Inhibitors 7. Selective serotonin re-uptake inhibitor 8. Serotonin and Noradrenaline Reuptake Inhibitor 9. Antidepressants 10. Tricyclic antidepressant 11. Reversable inhibitors of monoamine oxidase inhibitors
Interventions:
Interventions for preventing and reducing the use of physical restraints of older people in general hospital settings
1. Hospital 2. Physical Restraint
Interventions:
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia
1. Antithrombotic Agents 2. Antiplatelet Agent Therapy
Interventions:
Algorithm‐based pain management for people with dementia in nursing homes
1. Assessment Using Assessment Scale 2. Pain Assessment 3. Pain Management 4. Treatment algorithm
Interventions:
Early pharmacological interventions for universal prevention of post‐traumatic stress disorder (PTSD)
1. Early Treatment 2. Drug Therapy
Interventions:
Non‐pharmacological interventions for preventing delirium in hospitalised non‐ICU patients
1. Non-Pharmacological Interventions
Interventions:
Multi‐domain interventions for the prevention of dementia and cognitive decline
1. Non-Pharmacological Interventions 2. Pharmacotherapy
Interventions:
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
1. Ketamine 2. Glutamate receptor antagonist
Interventions:
Lamotrigine in the maintenance treatment of bipolar disorder
1. Lamotrigine
Interventions:
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
1. Amantadine 2. Ketamine 3. Memantine 4. Atomoxetine 5. Glutamate receptor modulators 6. Tramadol 7. Lanicemine 8. Dextromethorphan 9. Quinolinic acid 10. MK-0657 11. Riluzole
Interventions:
Enteral tube feeding for people with severe dementia
1. Enteral nutrition
Interventions:
Magnetic seizure therapy for treatment‐resistant depression
1. Magnetic seizure therapy
Interventions:
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
1. Antihypertensive Therapy 2. Antihypertensive agents
Interventions:
Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults
1. Recommendation To Discontinue A Procedure
Interventions:
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis
1. Galantamine 2. Rivastigmine 3. Donepezil
Interventions:
Antidepressant treatment for postnatal depression
1. Antidepressants
Interventions:
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
1. Memantine 2. Anticholinesterases
Interventions:
Pharmacological interventions for self‐harm in adults
1. Drug Therapy
Interventions:
Remotely delivered information, training and support for informal caregivers of people with dementia
1. Educational Material 2. Caregiver Support
Interventions:
Personally tailored activities for improving psychosocial outcomes for people with dementia in community settings
1. Activity Therapy
Interventions:
Behavioural activation therapy for depression in adults with non‐communicable diseases
1. Behavioral Activation Therapy
Interventions:
Avatar Therapy for people with schizophrenia or related disorders
1. Avatar therapy
Interventions:
Aspirin and other non‐steroidal anti‐inflammatory drugs for the prevention of dementia
1. Non-steroidal Anti-inflammatory Drug 2. Aspirin
Interventions:
Simulated presence therapy for dementia
1. Simulated presence therapy
Interventions:
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life
1. Cognitive training
Interventions:
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
1. Cognitive training
Interventions:
Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery
1. Functional Rehabilitation 2. Dementia Management
Interventions:
Psychosocial interventions for people with both severe mental illness and substance misuse
1. Psychosocial Intervention Strategy
Interventions:
Couple and family therapies for post‐traumatic stress disorder (PTSD)
1. Family Therapy 2. Couple Psychotherapy
Interventions:
Present‐centered therapy (PCT) for post‐traumatic stress disorder (PTSD) in adults
1. Present-centered therapy
Interventions:
Cerebrolysin for vascular dementia
1. Cerebrolysin
Interventions:
Pharmacological interventions for the treatment of delirium in critically ill adults
1. Intensive Care Unit
Interventions:
Multiple session early psychological interventions for the prevention of post‐traumatic stress disorder
1. Preventive 2. Early Treatment
Interventions:
Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses
1. Benzodiazepine
Interventions:
Antidepressants plus benzodiazepines for adults with major depression
1. Antidepressants 2. Benzodiazepine
Interventions:
Psychological therapies for preventing seasonal affective disorder
1. Preventive 2. Psychodynamic Psychotherapy 3. Integrative Psychotherapy 4. Cognitive Behavioral Therapy 5. Behavioral Therapy
Interventions:
Interventions for preventing delirium in older people in institutional long‐term care
1. Delirium Management
Interventions:
Benzodiazepines versus placebo for panic disorder in adults
1. Benzodiazepine derivatives hypnotics and sedatives
Interventions:
Cognitive training for people with mild to moderate dementia
1. Cognitive training
Interventions:
Memantine for dementia
1. Memantine
Interventions:
Electroconvulsive therapy for treatment‐resistant schizophrenia
1. Electroconvulsive therapy
Interventions:
Second‐generation antidepressants for preventing seasonal affective disorder in adults
1. Preventive 2. Antidepressants
Interventions:
Computerised cognitive training for preventing dementia in people with mild cognitive impairment
1. Cognitive training
Interventions:
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife
1. Cognitive training
Interventions:
Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia
1. Cognitive Behavioral Therapy 2. Usual Care
Interventions:
Interventions for preventing intensive care unit delirium in adults
1. Intensive Care Unit 2. Non-Pharmacological Interventions
Interventions:
Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia
1. Cognitive Behavioral Therapy
Interventions:
Valproate preparations for agitation in dementia
1. Valproate
Interventions:
Antidepressants for treating depression in dementia
1. Antidepressants
Interventions:
Environmental and behavioural modifications for improving food and fluid intake in people with dementia
1. Fluid Intake Encouragement 2. Feeding Tube 3. Food Intake Encouragement
Interventions:
Cholinesterase inhibitors for the treatment of delirium in non‐ICU settings
1. Anticholinesterases
Interventions:
Donepezil for dementia due to Alzheimer's disease
1. Donepezil
Interventions:
Couple therapy for depression
1. Outpatient Environment 2. Family, Systemic, Couple And Sex Therapy
Interventions:
Processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cognitive dysfunction following non‐cardiac and non‐neurosurgical procedures in adults
1. Auditory Evoked Potentials Monitoring 2. Surgical Department 3. Electroencephalographic Monitoring Regime
Interventions:
Antidepressants for preventing postnatal depression
1. Preventive 2. Antidepressants
Interventions:
Gamma‐aminobutyric acid agonists for antipsychotic‐induced tardive dyskinesia
1. Nonbenzodiazepine Benzodiazepine Receptor Agonists
Interventions:
Antidepressants versus placebo for panic disorder in adults
1. Antidepressants
Interventions:
Withdrawal versus continuation of long‐term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia
1. Antipsychotics
Interventions:
Calcium channel blockers for antipsychotic‐induced tardive dyskinesia
1. Calcium Channel Blockers
Interventions:
Cholinergic medication for antipsychotic‐induced tardive dyskinesia
1. Parasympathomimetic
Interventions:
Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia
1. Electroconvulsive therapy 2. Mindfulness-based Cognitive Therapy
Interventions:
Selective noradrenaline reuptake inhibitors for schizophrenia
1. Noradrenaline Reuptake Inhibitors
Interventions:
Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance misuse
1. Risperidone
Interventions:
Benzodiazepines for antipsychotic‐induced tardive dyskinesia
1. Benzodiazepine
Interventions:
Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia
1. Noradrenaline Reuptake Inhibitors
Interventions:
Anticholinergic medication for antipsychotic‐induced tardive dyskinesia
1. Anticholinergics
Interventions:
Aripiprazole (intramuscular) for psychosis‐induced aggression or agitation (rapid tranquillisation)
1. Aripiprazole
Interventions:
Benzodiazepines for psychosis‐induced aggression or agitation
1. Benzodiazepine
Interventions:
Zuclopenthixol dihydrochloride for schizophrenia
1. Zuclopenthixol dihydrochloride 2. Oral
Interventions:
Chlorpromazine versus penfluridol for schizophrenia
1. Chlorpromazine
Interventions:
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation)
1. Antipsychotics 2. Anticonvulsants 3. Rapid use 4. Benzodiazepine 5. Haloperidol
Interventions:
Vortioxetine for depression in adults
1. Vortioxetine
Interventions:
Antipsychotic combinations for schizophrenia
1. Antipsychotics 2. Combination Therapy
Interventions:
Communication skills training for mental health professionals working with people with severe mental illness
1. Communication Skills Training
Interventions:
Assistive technology for memory support in dementia
1. Assistive technology
Interventions:
Chlorpromazine versus clotiapine for schizophrenia
1. Chlorpromazine
Interventions:
Chlorpromazine versus metiapine for schizophrenia
1. Chlorpromazine
Interventions:
Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
1. Other Antipsychotics 2. Clozapine
Interventions:
Compulsory community and involuntary outpatient treatment for people with severe mental disorders
1. Compulsory Community Treatment
Interventions:
Risperidone versus placebo for schizophrenia
1. Oral 2. Risperidone
Interventions:
Implementation of treatment guidelines for specialist mental health care
1. Guideline implementation strategy
Interventions:
Droperidol for psychosis‐induced aggression or agitation
1. Droperidol
Interventions:
Haloperidol for long‐term aggression in psychosis
1. Haloperidol
Interventions:
Haloperidol plus promethazine for psychosis‐induced aggression
1. Intramuscular 2. Antipsychotics 3. Anticonvulsants 4. Promethazine 5. Benzodiazepine 6. Haloperidol
Interventions:
Valproate for schizophrenia
1. Valproate
Interventions:
Antihypertensive withdrawal for the prevention of cognitive decline
1. Recommendation to discontinue a therapy 2. Antihypertensive agents
Interventions:
Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults
1. Psychodynamic Psychotherapy 2. Supportive Verbal Psychotherapy 3. Cognitive Behavioral Therapy 4. Psychoeducation 5. Behavioral Therapy
Interventions:
Bifeprunox versus placebo for schizophrenia
1. Bifeprunox
Interventions:
Psychological therapies for children and adolescents exposed to trauma
1. Preventive
Interventions:
Continuation and maintenance treatments for depression in older people
1. Preventive 2. Antidepressants
Interventions:
Topiramate for acute affective episodes in bipolar disorder in adults
1. Topiramate
Interventions:
Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents
1. Preventive 2. Interpersonal Psychotherapy 3. Behavioral Therapy 4. Cognitive Behavioral Therapy
Interventions:
Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults
1. Measuring Patient-Reported Outcomes
Interventions:
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
1. Fluphenazine 2. Oral
Interventions:
Pharmacological interventions for clozapine‐induced sinus tachycardia
1. Drug Therapy
Interventions:
Psychosocial interventions for self‐harm in adults
1. Multifactorial Intervention 2. Case Management 3. Self-harm Behavior Management 4. Communication Interventions 5. Cognitive Behavioral Therapy
Interventions:
Chlorpromazine versus reserpine for schizophrenia
1. Chlorpromazine
Interventions:
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta‐analysis
1. Relaxation Exercise 2. Psychodynamic Psychotherapy 3. Psychoeducation 4. Supportive Verbal Psychotherapy 5. Cognitive Behavioral Therapy 6. Behavioral Therapy
Interventions:
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
1. Chlorpromazine
Interventions:
Psychological therapies for post‐traumatic stress disorder and comorbid substance use disorder
1. Psychotherapy 2. Trauma Therapy 3. Substance Use Therapy
Interventions:
Therapist‐supported Internet cognitive behavioural therapy for anxiety disorders in adults
1. Therapist-supported Internet Cognitive-Behavioral Therapy
Interventions:
Interventions for preventing delirium in hospitalised non‐ICU patients
1. Delirium Management
Interventions:
Antiglucocorticoid and related treatments for psychosis
1. Antipsychotics 2. Atypical antipsychotic
Interventions:
Statins for the prevention of dementia
1. Statin Prophylaxis
Interventions:
Interventions for self‐harm in children and adolescents
1. Self-harm Behavior Management 2. Remote 3. Tricyclic antidepressant 4. Group Psychotherapy 5. Cognitive Behavioral Therapy 6. Supportive Verbal Psychotherapy 7. Antipsychotics 8. Family Support 9. Antidepressants 10. Encouragement Of Compliance 11. Assessment For Risk Of Self Harm 12. Home 13. N-3 Fatty Acid Supplementation
Interventions:
Zuclopenthixol versus placebo for schizophrenia
1. Zuclopenthixol dihydrochloride 2. Zuclopenthixol decanoate 3. Zuclopenthixol acetate
Interventions:
Pharmacotherapy for chronic cognitive impairment in traumatic brain injury
1. Antipsychotics 2. Antidepressants 3. Choline 4. Psychostimulant 5. Dopamine Agonists
Interventions:
Asenapine versus placebo for schizophrenia
1. Asenapine
Interventions:
Lithium for schizophrenia
1. Lithium
Interventions:
Cognitive behavioural therapy (brief versus standard duration) for schizophrenia
1. Cognitive Behavioral Therapy
Interventions:
Rivastigmine for Alzheimer's disease
1. Rivastigmine 2. Oral 3. Transdermal
Interventions:
Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH)
1. Endoscopic Exteriorization Of Third Ventricle
Interventions:
Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa
1. Psychodynamic Psychotherapy 2. Integrative Psychotherapy 3. Cognitive Behavioral Therapy
Interventions:
Pharmacological interventions for self‐harm in adults
1. Antipsychotics 2. Antidepressants 3. Antiepileptics 4. Tricyclic antidepressant 5. N-3 Fatty Acid Supplementation
Interventions:
Treatments for delusional disorder
1. Antipsychotics 2. Mood stabilisers 3. Antidepressants 4. Psychotherapy
Interventions:
Opioids for agitation in dementia
1. Opioids
Interventions:
Augmentation of cognitive and behavioural therapies (CBT) with d‐cycloserine for anxiety and related disorders
1. Cognitive Behavioral Therapy 2. Cycloserine
Interventions:
Psychoeducation for siblings of people with severe mental illness
1. Psychoeducation
Interventions:
Aerobic exercise to improve cognitive function in older people without known cognitive impairment
1. Aerobic Exercise
Interventions:
Latrepirdine for Alzheimer's disease
1. Latrepirdine
Interventions:
Debriefing interventions for the prevention of psychological trauma in women following childbirth
1. Preventive 2. Debriefing Therapy
Interventions:
Psychoeducation (brief) for people with serious mental illness
1. Psychoeducation
Interventions:
Perphenazine for schizophrenia
1. Perphenazine
Interventions:
Cholinesterase inhibitors for rarer dementias associated with neurological conditions
1. Anticholinesterases
Interventions:
Fluphenazine decanoate (depot) and enanthate for schizophrenia
1. Antipsychotics 2. Fluphenazine enanthate 3. Fluphenazine decanoate 4. Oral
Interventions:
Pharmacotherapy for anxiety and comorbid alcohol use disorders
1. Drug Therapy
Interventions:
Haloperidol versus first‐generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
1. Haloperidol
Interventions:
Antidepressant treatment for postnatal depression
1. Adjunctive Care 2. Antidepressants
Interventions:
Flupenthixol versus low‐potency first‐generation antipsychotic drugs for schizophrenia
1. Flupentixol
Interventions:
Fluphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia
1. Fluphenazine
Interventions:
Alternating current cranial electrotherapy stimulation (CES) for depression
1. Alternating Current Therapy
Interventions:
Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD)
1. Preventive
Interventions:
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders
1. Flupenthixol Decanoate
Interventions:
Pericyazine for schizophrenia
1. Atypical antipsychotic 2. Periciazine
Interventions:
Carbamazepine for schizophrenia
1. Antipsychotics 2. Carbamazepine
Interventions:
Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression
1. Intravenous 2. Hypnotics And Sedatives
Interventions:
Sulpiride versus placebo for schizophrenia
1. Sulpiride
Interventions:
General physical health advice for people with serious mental illness
1. General health advice
Interventions:
Metal protein attenuating compounds for the treatment of Alzheimer's dementia
1. Clioquinol
Interventions:
Physical health care monitoring for people with serious mental illness
1. Physiological Monitoring Regime
Interventions:
Respite care for people with dementia and their carers
1. Respite Care Of Patient
Interventions:
Perazine for schizophrenia
1. Perazine
Interventions:
Chlorpromazine versus placebo for schizophrenia
1. Chlorpromazine
Interventions:
Aripiprazole versus other atypical antipsychotics for schizophrenia
1. Oral 2. Aripiprazole
Interventions:
Anticholinergic medication for non‐clozapine neuroleptic‐induced hypersalivation in people with schizophrenia
1. Anticholinergics
Interventions:
Agomelatine versus other antidepressive agents for major depression
1. Melatonin Receptor Agonists 2. Other Antidepressants 3. Agomelatine
Interventions:
Quetiapine versus other atypical antipsychotics for schizophrenia
1. Quetiapine
Interventions:
Haloperidol versus placebo for schizophrenia
1. Haloperidol 2. Oral
Interventions:
Pimozide for schizophrenia or related psychoses
1. Pimozide
Interventions:
Dietary supplements for preventing postnatal depression
1. Nutritional supplement
Interventions:
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
1. Valproate
Interventions:
Atypical antipsychotics for psychosis in adolescents
1. Atypical antipsychotic
Interventions:
Exercise for depression
1. Exercise therapy
Interventions:
Driving assessment for maintaining mobility and safety in drivers with dementia
1. Driving-related Medical Examination 2. Driving Assessment
Interventions:
Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
1. Cognitive rehabilitation therapy
Interventions:
Flow‐regulated versus differential pressure‐regulated shunt valves for adult patients with normal pressure hydrocephalus
1. Ventriculoperitoneal Shunt
Interventions:
Rivastigmine for vascular cognitive impairment
1. Rivastigmine
Interventions:
Quetiapine versus typical antipsychotic medications for schizophrenia
1. Quetiapine
Interventions:
Intermittent phototherapy versus continuous phototherapy for neonatal jaundice
1. Intermittent Administration 2. Phototherapy Of Newborn
Interventions:
Volume‐targeted versus pressure‐limited ventilation in neonates
1. Volume Controlled Ventilation 2. Mechanical ventilation
Interventions:
Early planned removal of umbilical venous catheters to prevent infection in newborn infants
1. Early Treatment 2. Removal Of Catheter
Interventions:
Cerebral near‐infrared spectroscopy monitoring for prevention of brain injury in very preterm infants
1. Preventive 2. Near-infrared Spectroscopy 3. Newborn Monitoring
Interventions:
Sildenafil for pulmonary hypertension in neonates
1. Sildenafil 2. Pulmonary Vasodilator
Interventions:
Fluid supplementation for neonatal unconjugated hyperbilirubinaemia
1. Fluids
Interventions:
Saline irrigation for the management of skin extravasation injury in neonates
1. Irrigation 2. Saline
Interventions:
Antibiotics for neonates born through meconium‐stained amniotic fluid
1. Preventive 2. Antibiotic Therapy
Interventions:
Orotracheal intubation in infants performed with a stylet versus without a stylet
1. Orotracheal Intubation 2. Stylet
Interventions:
Clonidine for sedation and analgesia for neonates receiving mechanical ventilation
1. Clonidine
Interventions:
Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants
1. Pulse Oximetry Monitoring 2. Oxygen Therapy
Interventions:
Repeated lumbar or ventricular punctures in newborns with intraventricular haemorrhage
1. Cerebral Ventricular Reservoir Device 2. Lumbar Puncture 3. Ventriculopuncture Of Brain
Interventions:
Frenotomy for tongue‐tie in newborn infants
1. Oral Frenectomy
Interventions:
Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries
1. Vitamin A
Interventions:
Skin‐to‐skin care for procedural pain in neonates
1. Mother 2. Kangaroo Care 3. Father 4. Nurse
Interventions:
Topical anaesthesia for needle‐related pain in newborn infants
1. Topical Anaesthetic 2. Prilocaine 3. Lidocaine 4. Tetracaine
Interventions:
Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit
1. Infusion Of Drug Or Medicament Via Intravenous Route 2. Midazolam
Interventions:
Cromolyn sodium for the prevention of chronic lung disease in preterm infants
1. Cromoglicic Acid 2. Nebulizer Therapy 3. Metered Dose Inhaler
Interventions:
Body positioning for spontaneously breathing preterm infants with apnoea
1. Positioning Patient
Interventions:
Nitric oxide for respiratory failure in infants born at or near term
1. Nitric Oxide 2. Inhaled
Interventions:
Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates
1. Corticosteroids - Nasal preparations 2. Preventive 3. Inhaled
Interventions:
Inhaled nitric oxide for respiratory failure in preterm infants
1. Nitric Oxide 2. Inhaled
Interventions:
Heparin for the treatment of thrombosis in neonates
1. Heparin
Interventions:
Infant position in neonates receiving mechanical ventilation
1. Supine positioning
Interventions:
Synchronized mechanical ventilation for respiratory support in newborn infants
1. Pressure Controlled Ventilation 2. High Frequency Positive Pressure Ventilation 3. Synchronized Intermittent Mandatory Ventilation 4. Pressure Controlled Simv
Interventions:
Responsive versus scheduled feeding for preterm infants
1. Demand Feeding
Interventions:
Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed
1. Enteral nutrition 2. Infant Formula 3. Infant Drinking/feeding Cup 4. Giving Expressed Breast Milk
Interventions:
Early additional food and fluids for healthy breastfed full‐term infants
1. Breastfeeding 2. Giving Oral Fluid 3. Food
Interventions:
Instruments for assessing readiness to commence suck feeds in preterm infants: effects on time to establish full oral feeding and duration of hospitalisation
1. Newborn Care Assessment 2. Breastfeeding Assessment 3. Instrument 4. Enteral Feeding Assessment
Interventions:
Sucrose for analgesia in newborn infants undergoing painful procedures
1. Sucrose 2. Infant Oral Pacifier 3. Oral
Interventions:
Epinephrine for transient tachypnea of the newborn
1. Epinephrine
Interventions:
Heparin for the prevention of intraventricular haemorrhage in preterm infants
1. Heparin
Interventions:
Co‐bedding in neonatal nursery for promoting growth and neurodevelopment in stable preterm twins
1. Co-Bedding 2. Infant Incubator 3. Newborn-infant Bed
Interventions:
Antimicrobial dressings for the prevention of catheter‐related infections in newborn infants with central venous catheters
1. Catheterization 2. Application Of Antimicrobial Dressing
Interventions:
Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants
1. Antithrombin III
Interventions:
Frequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newborns
1. Endotracheal Tube Suction
Interventions:
Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality
1. Measurement Of Transcutaneous Partial Pressure Of Carbon Dioxide
Interventions:
Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants
1. Medium Chain Triglycerides 2. Fat Emulsions 3. Olive Oil 4. Soybean Oil 5. Fish Oil
Interventions:
Diuretics for transient tachypnoea of the newborn
1. Diuretic
Interventions:
Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy
1. Provision Of External Compensating Shield
Interventions:
Specialist teams for neonatal transport to neonatal intensive care units for prevention of morbidity and mortality
1. Patient Transfer Management 2. Intensive Care Monitoring
Interventions:
Rescue high‐frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants
1. High Frequency Jet Ventilation
Interventions:
Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates
1. Peripherally Inserted Central Venous Catheter 2. Total Parenteral Nutrition
Interventions:
Antimicrobial‐impregnated central venous catheters for prevention of catheter‐related bloodstream infection in newborn infants
1. Antiseptics 2. Antibiotic-coated Catheter 3. Central Venous Catheter
Interventions:
Standardised formal resuscitation training programmes for reducing mortality and morbidity in newborn infants
1. Healthcare Professional 2. Cardiopulmonary Resuscitation Education 3. Resuscitation Of Neonate
Interventions:
Intravenous in‐line filters for preventing morbidity and mortality in neonates
1. Intravenous Line Filter
Interventions:
Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy
1. Regional Anesthesia
Interventions:
Strategies for the discontinuation of humidified high flow nasal cannula (HHFNC) in preterm infants
1. Weaning From Mechanically Assisted Ventilation 2. High Flow Oxygen Nasal Cannula
Interventions:
Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants
1. Prophylaxis 2. High Frequency Oscillatory Ventilation
Interventions:
Methods for securing endotracheal tubes in newborn infants
1. Tube Care: Endotracheal
Interventions:
Home‐ versus hospital‐based phototherapy for the treatment of non‐haemolytic jaundice in infants at more than 37 weeks' gestation
1. Phototherapy Of Newborn 2. Home
Interventions:
Physical activity programs for promoting bone mineralization and growth in preterm infants
1. Infant Massage 2. Physiotherapy
Interventions:
Early light reduction for preventing retinopathy of prematurity in very low birth weight infants
1. Covering Eye
Interventions:
Lung lavage for meconium aspiration syndrome in newborn infants
1. Fluorocarbon Ventilation 2. Bronchoalveolar Lavage 3. Lung Surfactants 4. Saline
Interventions:
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants
1. Ligation Of Patent Ductus Arteriosus
Interventions:
Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants
1. Enteral nutrition 2. Parenteral nutrition
Interventions:
Vasopressin and its analogues for the treatment of refractory hypotension in neonates
1. Vasopressin And Analogues
Interventions:
Nasal versus oral route for placing feeding tubes in preterm or low birth weight infants
1. Nasal Tube Feeding
Interventions:
Hydralazine in infants with persistent hypoxemic respiratory failure
1. Hydralazine
Interventions:
Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
1. Immunoglobulins 2. Fingolimod 3. Natalizumab 4. Glatiramer Acetate 5. Teriflunomide 6. Ocrelizumab 7. Pegylated interferon Beta-1a 8. Alemtuzumab 9. Daclizumab 10. Laquinimod 11. Interferon Beta-1a 12. Interferon Beta-1b 13. Mitoxantrone 14. Azathioprine 15. Dimethyl Fumarate
Interventions:
Local corticosteroid injection versus placebo for carpal tunnel syndrome
1. Corticosteroids 2. Local Anesthesia 3. Injection
Interventions:
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis
1. Botulinum Toxin 2. Drug Therapy 3. Ligation Of Salivary Duct 4. Complementary Therapy 5. Radiotherapy
Interventions:
Topical clonidine for neuropathic pain in adults
1. Clonidine 2. Topical
Interventions:
Ocrelizumab for multiple sclerosis
1. Ocrelizumab
Interventions:
Immunoglobulin for multifocal motor neuropathy
1. Intravenous 2. Immunoglobulin G
Interventions:
Siponimod for multiple sclerosis
1. Siponimod
Interventions:
Rituximab for people with multiple sclerosis
1. Rituximab
Interventions:
Memory rehabilitation for people with multiple sclerosis
1. Memory Rehabilitation
Interventions:
Interventions for promoting physical activity in people with neuromuscular disease
1. Encouragement and support 2. Physical activity
Interventions:
GLP‐1 receptor agonists for Parkinson's disease
1. Glucagon-like Peptide-1
Interventions:
Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
1. Epidermal growth factor receptor inhibitor 2. Tyrosine kinase inhibitor 3. Prophylaxis 4. Monoclonal Antibodies
Interventions:
Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease
1. Implantation of Neural Stem Cells 2. Implantation Of Olfactory Ensheathing Stem Cells 3. Autologous Peripheral Blood Stem Cell Transplant 4. Transplantation of Bone Marrow Mononuclear Cells
Interventions:
Interventions for preventing falls in people with multiple sclerosis
1. Physiotherapy 2. Drug Therapy 3. Complementary Therapy
Interventions:
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults
1. Indomethacin
Interventions:
Exercise therapy for chronic fatigue syndrome
1. Exercise therapy
Interventions:
Psychological therapies for the prevention of migraine in adults
1. Psychotherapy
Interventions:
Mixed exercise training for adults with fibromyalgia
1. Physical therapy exercises
Interventions:
Non‐pharmacological interventions for chronic pain in multiple sclerosis
1. Non-Pharmacological Interventions
Interventions:
Information provision for people with multiple sclerosis
1. Disease-specific information process
Interventions:
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
1. Serotonin and Noradrenaline Reuptake Inhibitor 2. Desvenlafaxine 3. Milnacipran 4. Duloxetine 5. Venlafaxine hydrochloride